Stephen Schultz, GW’s Vice President of Investor Relations, will present at two upcoming conferences:
CARLSBAD, Calif., Oct. 31, 2019 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc and its U.S. subsidiary Greenwich Biosciences Inc. (NASDAQ: GWPH, GW, the Company or the Group), the world leader in the science, development, and commercialization of cannabinoid prescription medicines, today announced that Stephen Schultz, GW’s Vice President of Investor Relations, will present at two upcoming conferences:
Can you be more specific about the content of your article? After reading it, I still have some doubts. Hope you can help me.